COVID-19 Vaccines Adapted to Fight Variants Will Not Require Long Clinical Trials: FDA

TUESDAY, Feb. 23, 2021 -- Long clinical trials will not be needed to prove the effectiveness of approved COVID-19 vaccines that have been adapted to protect against variants of the new coronavirus, the U.S. Food and Drug Administration said Monday....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news